YourBio Health and Turtle Health are teaming up to introduce a new kind of AMH testing. According to a trial published in ‘Reproductive Biology and Endocrinology’ the TAP II device, when utilized as part of Turtle Health’s lab-developed home test, can reliably produce similar results to in-clinic venipuncture. The study, conducted in 41 women of reproductive age and sponsored by Turtle Health,…
Founded in 2020, Daylight is the first digital banking platform in the U.S. specifically designed for and by the LGBTQIA+ community. Now the company has added $15M in funding to expand its services to support LGBTQ+ people looking to start and grow their families. This latest round of funding was led by Anthemis Group with participation from CMFG Ventures, Kapor Capital, Citi…
Cyclica, a biotech company that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives for low-data biological protein targets with support from a grant from the Bill & Melinda Gates Foundation. The CAD$2.4M (USD$1.8M) grant enables Cyclica to apply its validated, AI-enabled drug discovery platform towards the discovery of expanded contraceptive options. To date, research on discovering…
ARCH, the company behind ‘Torch Clinic’, a tech-enabled company has raised 230M Yen ($1.65M USD) in seed funding from University of Tokyo Edge Capital Partners, XTech Ventures, and ANRI. Since its founding in 2021, ARCH has been working on various digital health services in the area of reproductive and gynecological health (B2C & B2B). The company’s tech-enabled ‘Torch Clinic’ opened earlier this…
Sebela Pharmaceuticals is launching a new division of the company named Sebela Women’s Health along with the appointment of Kelly Culwell, MD, as Head of Research and Development for the division. Bringing more than twenty years’ experience in women’s health across public, private and non-profit organizations, Dr. Culwell joins the team when the company is in the final stages of clinical development of two…
Contraline, the company working on developing male contraceptive implants, has announced the first hydrogel-based male contraceptive implants were performed in humans in a clinical trial. These procedures represent a significant milestone for the development of the company’s flagship product, ADAM, a male contraceptive that is long-lasting, non-hormonal, and non-permanent. Four men were implanted with ADAM at Epworth Freemasons Hospital in Melbourne, Australia,…
TMRW Life Sciences, a fertility technology company modernizing and automating specimen management, has received FDA510(k) clearance for the CryoRobot Select (CRS). TMRW’s CryoRobot Select is the only FDA-cleared automated solution that digitally tracks, monitors and manages frozen eggs and embryos used in IVF. Fully integrated with TMRW’s proprietary ivfOS software, which assigns a unique identifier for each specimen, the CryoRobot Select represents a…
Continuing its mission to lead advancements in reproductive science and medicine, Inception Fertility has partnered with other leading technology companies on four fertility studies with the goal to elevate the patient experience, evolve fertility services, and enhance pregnancy outcomes. Led by Alice Domar, PhD, Chief Compassion Officer at Inception, the clinical research team is designed to give Inception tools to better understand and…
